74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
GE HealthCare Technologies
Suletud
SektorTervishoid
79.4 -0.19
Ülevaade
Aktsiahinna muutus
24h
Min
78.71
Max
79.83
Sissetulek | 268M 738M |
|---|---|
Müük | 456M 5.3B |
P/E Sektori keskmine | 18.597 63.778 |
Aktsiakasum | 1.45 |
Dividenditootlus | 0.17 |
Kasumimarginaal | 13.875 |
Töötajad | 53,000 |
EBITDA | 154M 1.1B |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +26.78% upside |
Dividenditootlus Sektori keskmine | 0.17% 2.39% |
|---|---|
Järgmine tulemuste avaldamine | 29. apr 2025 |
Järgmine dividendimakse kuupäev | 15. mai 2025 |
Järgmine aktsia dividendi kuupäev (ex-date) | 25. apr 2025 |
Turukapital | -3.7B 37B |
|---|---|
Eelmine avamishind | 79.59 |
Eelmine sulgemishind | 79.4 |
Uudiste sentiment
By Acuity
3%
97%
1 / 386 Pingereas Healthcare
GE HealthCare Technologies Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
GE HealthCare Technologies Prognoos
Hinnasiht
By TipRanks
26.78% tõus
12 kuu keskmine prognoos
Keskmine 100.88 USD 26.78%
Kõrge 110 USD
Madal 86 USD
Põhineb 10 Wall Streeti analüütiku instrumendi GE HealthCare Technologies 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
1 / 386 Pingereas Tervishoid
Uudiste sentiment
Väga tugevad tõusu märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Üle keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest GE HealthCare Technologies
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
